Physicians surveyed trainees across three large metropolitan residency programs for their findings, shared in Clinical Imaging.

Researchers called for better guidelines that cover when clinicians should consider stopping anticoagulation therapy for patients with AFib. The risks of such medication, they observed, may often outweigh the benefits. 

The full findings are scheduled to be presented May 16 at ACC.21. 

Such injectable agents have been administered routinely for years to detect heart disease, assess risk, and identify tumors throughout the abdomen.

The Santa Clara, California-based company has raised more than $49 million in funding and inked partnerships with providers including RadNet and the Mallinckrodt Institute of Radiology. 

Chairman and CEO Ran Poliakine said the setback stems from a third-party supplier of a key ceramic tube in its Nanox.ARC technology.

University of Washington Medicine researchers will develop a database of records outlining follow-up costs, diagnoses and health outcomes associated with various incidentalomas.

“As much as 80% of a person’s health is determined by the social and economic conditions of their environment,” one specialist said. 

President and CEO of the nuclear medicine company Stephen Merrick spoke about the move at “From Belgium to Beloit, Wisconsin," an event celebrating the news.

A medical AI startup focused on breast cancer diagnostics has uncloaked from stealth mode, appointing an MD as CEO and concertedly promoting its initial software offering seven months after the FDA approved the product.